Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal

Alejandra S Guberman1, María E Scassa, Eduardo T Cánepa

  • 1Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Pabellón II Piso 4, Ciudad Universitaria, 1428 Buenos Aires, Argentina.

Insights

12-O-tetradecanoylphorbol-13-acetate (TPA) represses 5-aminolevulinate synthase (ALAS) gene expression through protein kinase C (PKC), PI3K, ERK, and JNK signaling pathways. These pathways converge on p90RSK, highlighting crosstalk in TPA-mediated ALAS repression.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • 12-O-tetradecanoylphorbol-13-acetate (TPA) is a potent tumor promoter that activates transcription factors like AP-1 and protein kinase C (PKC).
  • TPA is known to repress 5-aminolevulinate synthase (ALAS) gene expression, a key enzyme in heme biosynthesis, but the underlying signaling pathways remain unclear.
  • Understanding these pathways is crucial for comprehending TPA's biological effects and potential therapeutic interventions.

Purpose of the Study:

  • To elucidate the specific signal transduction pathways mediating TPA-induced repression of ALAS gene expression.
  • To investigate the roles of various signaling cascades, including PKC, PI3K, ERK, and JNK, in TPA's regulation of ALAS.
  • To explore the crosstalk and convergence points among these pathways.

Main Methods:

  • Utilized human hepatoma HepG2 cells for experiments.
  • Employed transient overexpression of regulatory proteins and small molecule inhibitors to probe signaling pathways.
  • Analyzed endogenous ALAS mRNA levels and the activity of a reporter construct containing the ALAS promoter region.

Main Results:

  • Demonstrated the crucial involvement of PKCalpha, phosphatidylinositol 3-kinase (PI3K), extracellular-signal regulated kinase (ERK1/2), and c-Jun N-terminal kinase (JNK) in TPA's effect on ALAS.
  • Showed that ERK activation by TPA occurs independently of the Ras/Raf/MEK pathway.
  • Identified p90RSK as a potential convergence point for PI3K and ERK signaling and elucidated crosstalk among the involved cascades.

Conclusions:

  • The repression of ALAS gene expression by TPA is mediated by a complex network involving PKC, PI3K, ERK, and JNK signaling.
  • p90RSK acts as a key convergent node in these pathways.
  • The findings support a model of competition between AP-1 and CREB for CBP, influencing TPA-mediated ALAS repression.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...